McHale Duncan 4
4 · Evelo Biosciences, Inc. · Filed May 10, 2018
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option
2018-05-08+79,052→ 79,052 totalExercise: $16.00Exp: 2028-05-08→ Common Stock (79,052 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the grant date and vests in equal quarterly installments over a three year period thereafter.